In the last 12 months, insiders at Tvardi Therapeutics, Inc. ($TVRD) filed 110 transactions with the SEC: 0 open-market purchases totaling $0 and 33 sales totaling $526,002. Net insider sentiment: net selling.
Tvardi Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Goncalves Joana (Chief Medical Officer) — 7 transactions totaling $152,791
- Posner Christopher (President and CEO) — 6 transactions totaling $142,465
- Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) — 4 transactions totaling $89,972
- Terrillion Scott (Sec'y; Chief Compliance & G.C.) — 4 transactions totaling $81,643
- Posner Christopher (PRESIDENT AND CEO) — 9 transactions totaling $36,780
View all SEC Filings for Tvardi Therapeutics, Inc. (TVRD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 9,377,079 | 9999.99% | 0.16% |
| Jan. 29, 2026 | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 9,377,079 | 9999.99% | 0.48% |
| Jan. 29, 2026 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 9,377,079 | 9999.99% | 1.23% |
| Jan. 29, 2026 | Conn Avi Daniel | Chief Financial Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 9,377,079 | 9999.99% | 0.48% |
| Dec. 16, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 9,377,079 | 9999.99% | 0.04% |
| Dec. 16, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 9,377,079 | 9999.99% | 0.19% |
| Dec. 16, 2025 | Conn Avi Daniel | Chief Financial Officer | A | Employee Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 9,377,079 | 9999.99% | 0.19% |
| Dec. 16, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 9,377,079 | 9999.99% | 0.51% |
| July 7, 2025 | Tweardy Samuel David | Not found | J | Common Stock | 315658 | $0.00 | 315,658.0000 | 8,455,223 | 50.00% | 3.73% |
| July 7, 2025 | Tweardy Samuel David | Not found | J | Common Stock | 315658 | $0.00 | 315,658.0000 | 8,455,223 | 50.00% | 3.73% |
| April 15, 2025 | HALL WALLACE L JR | Not found | A | Common Stock | 44712 | $0.00 | 246,756.0000 | 1,524,116 | 22.13% | 2.93% |
| April 15, 2025 | HALL WALLACE L JR | Not found | A | Common Stock | 202044 | $0.00 | 246,756.0000 | 1,524,116 | 451.88% | 13.26% |
| April 15, 2025 | Wirk Shaheen | Not found | A | Common Stock | 176030 | $0.00 | 439,194.0000 | 1,524,116 | 66.89% | 11.55% |
| April 15, 2025 | Wirk Shaheen | Not found | A | Common Stock | 263164 | $0.00 | 439,194.0000 | 1,524,116 | 149.50% | 17.27% |
| April 17, 2025 | Smith Cynthia | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 17, 2025 | HALL WALLACE L JR | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 17, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 10820 | $0.00 | 10,820.0000 | 1,524,116 | 9999.99% | 0.71% |
| April 17, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 7213 | $0.00 | 7,213.0000 | 1,524,116 | 9999.99% | 0.47% |
| April 17, 2025 | Chen Yixin | VP, Chem, Mfg and Ctrls | A | Employee Stock Option (right to buy) | 7213 | $0.00 | 7,213.0000 | 1,524,116 | 9999.99% | 0.47% |
| April 17, 2025 | Conn Avi Daniel | Chief Financial Officer | A | Employee Stock Option (right to buy) | 43547 | $0.00 | 43,547.0000 | 1,524,116 | 9999.99% | 2.86% |
| April 17, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 36210 | $0.00 | 36,210.0000 | 1,524,116 | 9999.99% | 2.38% |
| April 17, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 182320 | $0.00 | 182,320.0000 | 1,524,116 | 9999.99% | 11.96% |
| April 17, 2025 | Shiff Susan Ph.D. | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 17, 2025 | Wirk Shaheen | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 17, 2025 | WYZGA MICHAEL S | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 17, 2025 | Shah Sujal | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 15, 2025 | Wirk Shaheen | Not found | A | Stock Option (right to buy) | 2011 | $0.00 | 2,011.0000 | 1,524,116 | 9999.99% | 0.13% |
| April 15, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 11399 | $0.00 | 11,399.0000 | 1,524,116 | 9999.99% | 0.75% |
| April 15, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 3352 | $0.00 | 3,352.0000 | 1,524,116 | 9999.99% | 0.22% |
| April 15, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 74049 | $0.00 | 74,049.0000 | 1,524,116 | 9999.99% | 4.86% |
| April 15, 2025 | WYZGA MICHAEL S | Not found | A | Stock Option (right to buy) | 18441 | $0.00 | 18,441.0000 | 1,524,116 | 9999.99% | 1.21% |
| April 15, 2025 | Chen Yixin | VP, Chem, Mfg and Ctrls | A | Employee Stock Option (right to buy) | 14752 | $0.00 | 14,752.0000 | 1,524,116 | 9999.99% | 0.97% |
| April 15, 2025 | Shah Sujal | Not found | A | Stock Option (right to buy) | 10394 | $0.00 | 10,394.0000 | 1,524,116 | 9999.99% | 0.68% |
| April 15, 2025 | Shah Sujal | Not found | A | Stock Option (right to buy) | 8047 | $0.00 | 8,047.0000 | 1,524,116 | 9999.99% | 0.53% |
| April 15, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 16764 | $0.00 | 16,764.0000 | 1,524,116 | 9999.99% | 1.10% |
| April 15, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 5364 | $0.00 | 5,364.0000 | 1,524,116 | 9999.99% | 0.35% |
| April 15, 2025 | Conn Avi Daniel | Chief Financial Officer | A | Employee Stock Option (right to buy) | 89053 | $0.00 | 89,053.0000 | 1,524,116 | 9999.99% | 5.84% |
| April 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 207881 | $0.00 | 207,881.0000 | 1,524,116 | 9999.99% | 13.64% |
| April 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Optyion (right to buy) | 2011 | $0.00 | 2,011.0000 | 1,524,116 | 9999.99% | 0.13% |
| April 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A | Employee Stock Option (right to buy) | 160940 | $0.00 | 160,940.0000 | 1,524,116 | 9999.99% | 10.56% |
| April 15, 2025 | HALL WALLACE L JR | Not found | J | Common Stock | 44712 | $0.00 | 246,756.0000 | 1,524,116 | 22.13% | 2.93% |
| April 15, 2025 | HALL WALLACE L JR | Not found | J | Common Stock | 202044 | $0.00 | 246,756.0000 | 1,524,116 | 451.88% | 13.26% |
| April 15, 2025 | Wirk Shaheen | Not found | A | Common Stock | 4191 | $0.00 | 443,385.0000 | 1,524,116 | 0.95% | 0.27% |
| April 15, 2025 | Wirk Shaheen | Not found | J | Common Stock | 176030 | $0.00 | 443,385.0000 | 1,524,116 | 65.84% | 11.55% |
| April 15, 2025 | Wirk Shaheen | Not found | J | Common Stock | 263164 | $0.00 | 443,385.0000 | 1,524,116 | 146.02% | 17.27% |
| Feb. 28, 2025 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S | Common Stock | 163 | $4.76 | 7,190.0000 | 4,562,738 | 2.22% | 0.00% |
| Feb. 28, 2025 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 583 | $4.75 | 13,109.0000 | 4,562,738 | 4.26% | 0.01% |
| Feb. 4, 2025 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 372 | $4.72 | 13,692.0000 | 4,562,738 | 2.65% | 0.01% |
| Nov. 4, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 3668 | $0.29 | 168,768.0000 | 2,574,767 | 2.13% | 0.14% |
| Aug. 1, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 4149 | $0.35 | 172,436.0000 | 2,574,767 | 2.35% | 0.16% |
| June 4, 2024 | Shiff Susan Ph.D. | Not found | A | Common Stock | 150647 | $0.00 | 202,085.0000 | 1,516,336 | 292.87% | 9.93% |
| June 4, 2024 | Boudreau Helen M | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 4, 2024 | von Moltke Lisa | Not found | A | Common Stock | 150647 | $0.00 | 183,009.0000 | 1,516,336 | 465.51% | 9.93% |
| June 4, 2024 | von Moltke Lisa | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 4, 2024 | Ives Jeffrey L. | Not found | A | Common Stock | 150647 | $0.00 | 198,485.0000 | 1,516,336 | 314.91% | 9.93% |
| June 4, 2024 | Ives Jeffrey L. | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 4, 2024 | VOGELBAUM MARTIN | Not found | A | Stock Option (Right to Buy) | 390000 | $0.00 | 390,000.0000 | 1,516,336 | 9999.99% | 25.72% |
| June 4, 2024 | VOGELBAUM MARTIN | Not found | A | Common Stock | 301295 | $0.00 | 411,007.0000 | 1,516,336 | 274.62% | 19.87% |
| June 4, 2024 | Shiff Susan Ph.D. | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 4, 2024 | Boudreau Helen M | Not found | A | Common Stock | 150647 | $0.00 | 150,647.0000 | 1,516,336 | 9999.99% | 9.93% |
| May 2, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 3936 | $0.75 | 176,585.0000 | 1,516,336 | 2.18% | 0.26% |
| April 5, 2024 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S | Common Stock | 2753 | $0.83 | 88,247.0000 | 1,516,336 | 3.03% | 0.18% |
| April 5, 2024 | Goncalves Joana | CHIEF MEDICAL OFFICER | S | Common Stock | 2753 | $0.83 | 53,365.0000 | 1,516,336 | 4.91% | 0.18% |
| Feb. 29, 2024 | Goncalves Joana | CHIEF MEDICAL OFFICER | S | Common Stock | 3293 | $0.89 | 56,118.0000 | 4,512,422 | 5.54% | 0.07% |
| Feb. 29, 2024 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S | Common Stock | 3293 | $0.89 | 91,000.0000 | 4,512,422 | 3.49% | 0.07% |
| Feb. 29, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 5834 | $0.89 | 180,521.0000 | 4,512,422 | 3.13% | 0.13% |
| Feb. 8, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 35575 | $0.53 | 186,355.0000 | 4,512,422 | 16.03% | 0.79% |
| Feb. 8, 2023 | Maynard Ryan D | CHIEF FINANCIAL OFFICER | S | Common Stock | 5488 | $0.53 | 8,012.0000 | 4,471,130 | 40.65% | 0.12% |
| Feb. 8, 2023 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S | Common Stock | 7770 | $0.53 | 94,293.0000 | 4,471,130 | 7.61% | 0.17% |
| Feb. 8, 2023 | Goncalves Joana | CHIEF MEDICAL OFFICER | S | Common Stock | 7770 | $0.53 | 59,411.0000 | 4,471,130 | 11.57% | 0.17% |
| Feb. 1, 2024 | Maynard Ryan D | CHIEF FINANCIAL OFFICER | A | Common Stock | 13500 | $0.00 | 13,500.0000 | 4,512,422 | 9999.99% | 0.30% |
| Feb. 1, 2024 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | A | Common Stock | 13500 | $0.00 | 102,063.0000 | 4,512,422 | 15.24% | 0.30% |
| Feb. 1, 2024 | Goncalves Joana | CHIEF MEDICAL OFFICER | A | Common Stock | 13500 | $0.00 | 67,181.0000 | 4,512,422 | 25.15% | 0.30% |
| Feb. 1, 2024 | Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | A | Common Stock | 13500 | $0.00 | 167,247.0000 | 4,512,422 | 8.78% | 0.30% |
| Feb. 1, 2024 | Posner Christopher | PRESIDENT AND CEO | A | Common Stock | 62500 | $0.00 | 226,911.0000 | 4,512,422 | 38.01% | 1.39% |
| Feb. 1, 2024 | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 4981 | $0.55 | 221,930.0000 | 4,512,422 | 2.20% | 0.11% |
| Nov. 2, 2023 | Posner Christopher | President and CEO | S | Common Stock | 3796 | $1.22 | 164,411.0000 | 54,235,695 | 2.26% | 0.01% |
| Aug. 3, 2023 | Posner Christopher | President and CEO | S | Common Stock | 4307 | $3.07 | 168,207.0000 | 54,002,988 | 2.50% | 0.01% |
| Aug. 2, 2023 | Boudreau Helen M | Director | A | Stock Option (Right to Buy) | 155747 | $0.00 | 155,747.0000 | 54,002,988 | 9999.99% | 0.29% |
| June 23, 2023 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S | Common Stock | 2483 | $3.51 | 88,563.0000 | 53,872,038 | 2.73% | 0.00% |
| June 23, 2023 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 2993 | $3.51 | 153,747.0000 | 53,872,038 | 1.91% | 0.01% |
| June 23, 2023 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2723 | $3.51 | 53,681.0000 | 53,872,038 | 4.83% | 0.01% |
| June 1, 2023 | Ives Jeffrey L. | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |
| June 1, 2023 | BAINS HARRISON M JR | Director | A | Common Stock | 32362 | $0.00 | 57,438.0000 | 53,872,038 | 129.06% | 0.06% |
| June 1, 2023 | BAINS HARRISON M JR | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |
| June 1, 2023 | VOGELBAUM MARTIN | Director | A | Stock Option (Right to Buy) | 89923 | $0.00 | 89,923.0000 | 53,872,038 | 9999.99% | 0.17% |
| June 1, 2023 | VOGELBAUM MARTIN | Director | A | Common Stock | 64724 | $0.00 | 109,712.0000 | 53,872,038 | 143.87% | 0.12% |
| June 1, 2023 | von Moltke Lisa | Director | A | Common Stock | 32362 | $0.00 | 32,362.0000 | 53,872,038 | 9999.99% | 0.06% |
| June 1, 2023 | von Moltke Lisa | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |
| June 1, 2023 | Shiff Susan Ph.D. | Director | A | Common Stock | 32362 | $0.00 | 51,438.0000 | 53,872,038 | 169.65% | 0.06% |
| June 1, 2023 | Shiff Susan Ph.D. | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |
| June 1, 2023 | Ives Jeffrey L. | Director | A | Common Stock | 32362 | $0.00 | 47,838.0000 | 53,872,038 | 209.11% | 0.06% |
| May 5, 2023 | Posner Christopher | President and CEO | S | Common Stock | 3869 | $4.40 | 172,514.0000 | 53,872,038 | 2.19% | 0.01% |
| April 4, 2023 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2481 | $4.91 | 56,404.0000 | 53,872,038 | 4.21% | 0.00% |
| April 4, 2023 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S | Common Stock | 2481 | $4.91 | 91,046.0000 | 53,872,038 | 2.65% | 0.00% |
| April 4, 2023 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 2733 | $4.91 | 156,740.0000 | 53,872,038 | 1.71% | 0.01% |
| March 3, 2023 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 6802 | $9.71 | 159,473.0000 | 4,471,130 | 4.09% | 0.15% |
| March 3, 2023 | Posner Christopher | President and CEO | S | Common Stock | 5987 | $9.71 | 176,383.0000 | 4,471,130 | 3.28% | 0.13% |
| March 3, 2023 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 6221 | $9.71 | 58,885.0000 | 4,471,130 | 9.56% | 0.14% |
| March 3, 2023 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S | Common Stock | 6256 | $9.71 | 93,527.0000 | 4,471,130 | 6.27% | 0.14% |
| March 1, 2023 | Maynard Ryan D | Chief Financial Officer | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |
| March 1, 2023 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |
| March 1, 2023 | Goncalves Joana | Chief Medical Officer | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |
| March 1, 2023 | Posner Christopher | President and CEO | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 4,471,130 | 9999.99% | 5.59% |
| March 1, 2023 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |
| Feb. 16, 2023 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2265 | $10.20 | 65,106.0000 | 4,471,130 | 3.36% | 0.05% |
| Feb. 2, 2023 | Posner Christopher | President and CEO | S | Common Stock | 4191 | $11.80 | 182,370.0000 | 4,471,130 | 2.25% | 0.09% |
| Jan. 17, 2023 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2265 | $10.81 | 67,371.0000 | 4,471,130 | 3.25% | 0.05% |
| Jan. 2, 2023 | von Moltke Lisa | Director | A | Stock Option (Right to Buy) | 45841 | $0.00 | 45,841.0000 | 4,471,130 | 9999.99% | 1.03% |
| Dec. 29, 2022 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2265 | $10.18 | 69,636.0000 | 53,726,123 | 3.15% | 0.00% |